Health Canada approves Ipsen’s Sohonos (palovarotene) as the first approved treatment for fibrodysplasia ossificans progressiva

24 January 2022 - Ipsen today announced the Health Canada approval of Sohonos (palovarotene), an oral selective retinoic-acid receptor gamma agonist ...

Read more →

Canada approves Pfizer COVID drug

18 January 2022 - Canada’s health regulator has approved a pill by Pfizer that treats the effects of COVID-19. ...

Read more →

Quebec to impose health tax on unvaccinated Canadians

12 January 2022 - The Canadian province of Quebec will charge a health tax to residents who are not vaccinated ...

Read more →

JAMP and Alvotech announce Canadian approval of Simlandi, a high concentration biosimilar to Humira, providing access to previously unavailable versions in Canada

10 January 2021 - Health Canada rules that 40 mg/0.4 mL and 80 mg/0.8 mL presentations of Simlandi are not subject ...

Read more →

Celltrion acquires approval for its new Humira 'Yuflyma' in Canada

30 December 2021 - Celltrion announced on December 30 that it won marketing approval from Health Canada for "Yuflyma", a ...

Read more →

SIGA announces Health Canada regulatory approval of oral TPOXX

1 December 2021 - SIGA Technologies today announced that Health Canada has approved oral Tpoxx (tecovirimat) as an extraordinary use new ...

Read more →

GSK’s Jemperli (dostarlimab for injection) approved in Canada as an anti-PD-1 therapy for recurrent or advanced endometrial cancer

15 December 2021 - GSK announces today that it has been granted Notice of Compliance with conditions for its endometrial ...

Read more →

Valeo Pharma obtains public reimbursement for Enerzair Breezhaler and Atectura Breezhaler in Quebec and Nova Scotia

15 December 2021 - Public reimbursement now includes Alberta, Quebec and Nova Scotia, representing approximately 37% of the Canadian population. ...

Read more →

VBI Vaccines announces filing of new drug submission for 3 antigen hepatitis B vaccine to Health Canada

9 December 2021 - VBI Vaccines today announced the filing of a new drug submission to Health Canada for the Company’s ...

Read more →

Canada's national strategy for drugs for rare diseases needs a holistic approach

8 December 2021 - International report summarises drugs for rare disease best practices and recommendations. ...

Read more →

Pfizer Canada initiates submission to Health Canada for COVID-19 oral anti-viral candidate

1 December 2021 - Pfizer Canada today initiated the filing of a rolling new drug submission with Health Canada for its ...

Read more →

Lilly Canada concludes successful negotiation with the Pan-Canadian Pharmaceutical Alliance for Baqsimi (glucagon nasal powder)

30 November 2021 - Lilly Canada is pleased to announce the completion of a successful negotiation with the pan-Canadian Pharmaceutical Alliance ...

Read more →

What happened to the promise of universal pharmacare?

25 November 2021 - Canada is the only developed country in the world with a universal health care system that ...

Read more →

It’s time to better support the three million Canadians with a rare disease

25 November 2021 - After finding out her private health insurer would no longer pay for a drug helping with ...

Read more →

Shingrix approved in Canada for adults at increased risk of shingles due to immunodeficiency or immunosuppression

25 November 2021 - GlaxoSmithKline today announced that Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been approved in Canada for the prevention ...

Read more →